Skip to main content

Animations

MJFF Publications

5841 - 5850 of 9034 Results
Title
Year
  • Year
  • 2022
  • 2025
  • 2015
  • 2019
  • 2018
  • 2018
  • 2014
  • 2017
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: Palladium-Catalyzed α-Arylation of Cyclic β-Dicarbonyl Compounds for the Synthesis of CaV1.3 Inhibitors
    Journal Name: ACS Omega
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acsomega.2c00889
    Citation Count: 7
  • A validation study of the Clinician's Tardive Inventory (CTI)
    2025
    Summary Details
    RESTRICTED
    Title: A validation study of the Clinician's Tardive Inventory (CTI)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107812
    Citation Count: 0
  • Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers
    2015
    Summary Details
    RESTRICTED
    Title: Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.007
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.27728
    Citation Count: 49
  • Summary Details
    OPEN
    Title: The Binding of BF-227-Like Benzoxazoles to Human α-Synuclein and Amyloid β Peptide Fibrils
    Journal Name: Molecular Imaging
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/1536012118796297
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The G2019S mutation in LRRK2 imparts resiliency to kinase inhibition
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.012
    Citation Count: 46
  • Summary Details
    OPEN
    Title: RETRACTED: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1038/mt.2014.129
    Citation Count: 82
  • Summary Details
    OPEN
    Title: The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.01.012
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines9050514
    Citation Count: 6
  • PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)
    2020
    Summary Details
    RESTRICTED
    Title: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.